DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 95 filers reported holding DYNE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,572 | +1167.7% | 175,387 | +1502.7% | 0.00% | – |
| Q2 2023 | $124 | -96.3% | 10,943 | -96.2% | 0.00% | -100.0% |
| Q1 2023 | $3,357 | +641.1% | 291,310 | +645.5% | 0.00% | – |
| Q4 2022 | $453 | -99.9% | 39,078 | +1.0% | 0.00% | – |
| Q3 2022 | $493,000 | +96.4% | 38,708 | +5.9% | 0.00% | – |
| Q2 2022 | $251,000 | -28.5% | 36,560 | +0.3% | 0.00% | – |
| Q1 2022 | $351,000 | -17.4% | 36,458 | +2.0% | 0.00% | – |
| Q4 2021 | $425,000 | -28.0% | 35,758 | -1.7% | 0.00% | – |
| Q3 2021 | $590,000 | -94.2% | 36,358 | -92.5% | 0.00% | -100.0% |
| Q4 2020 | $10,184,000 | +2.6% | 484,952 | -1.3% | 0.00% | 0.0% |
| Q3 2020 | $9,923,000 | – | 491,471 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,220,034 | $25,730,194 | 34.58% |
| MPM ASSET MANAGEMENT LLC | 4,951,303 | $57,385,602 | 24.01% |
| Atlas Venture Life Science Advisors, LLC | 9,869,483 | $114,387,308 | 13.78% |
| Logos Global Management LP | 2,150,000 | $24,918,500 | 2.92% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 641,068 | $7,417,157 | 2.29% |
| Deep Track Capital, LP | 2,684,200 | $31,109,878 | 1.31% |
| EcoR1 Capital, LLC | 2,322,384 | $26,916,431 | 0.82% |
| Vivo Capital, LLC | 577,642 | $6,695 | 0.77% |
| HighVista Strategies LLC | 102,431 | $1,187,175 | 0.70% |
| Monashee Investment Management LLC | 123,719 | $1,433,903 | 0.62% |